CooperSurgical is currently facing numerous lawsuits stemming from the recall of its embryo culture solution amid concerns that the solution may be causing embryo loss during in vitro fertilization (IVF) procedures. This product is widely utilized in IVF treatments across fertility clinics worldwide. Despite the recall, CooperSurgical has not issued a public notice or statement regarding the matter. The implications of this situation could be profound, affecting families in America and globally who are left questioning whether their embryo loss was due to this defective product.
The potential impact of this toxic solution on countless affected couples presents a tragic circumstance—not due to chance or the inherent challenges of fertility treatments, but allegedly due to negligence and the distribution of faulty products by CooperSurgical Inc. In essence, a prominent pharmaceutical company released a product into the market that they knew could impair embryo development.